<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>α-synuclein in Parkinson&#8217;s disease &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/%ce%b1-synuclein-in-parkinsons-disease/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 13 Oct 2025 10:58:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>α-synuclein in Parkinson&#8217;s disease &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Breakthroughs in PET Imaging for Neurodegenerative Proteins</title>
		<link>https://bioengineer.org/breakthroughs-in-pet-imaging-for-neurodegenerative-proteins/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 13 Oct 2025 10:58:29 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Amyloid-β and tau biomarkers]]></category>
		<category><![CDATA[Neurodegenerative disease PET imaging]]></category>
		<category><![CDATA[Protein aggregate diagnostics]]></category>
		<category><![CDATA[TDP43 and FUS proteinopathies]]></category>
		<category><![CDATA[α-synuclein in Parkinson's disease]]></category>
		<guid isPermaLink="false">https://bioengineer.org/breakthroughs-in-pet-imaging-for-neurodegenerative-proteins/</guid>

					<description><![CDATA[Neurodegenerative diseases are a significant concern in modern medicine, impacting millions of individuals globally. Prominent disorders such as Alzheimer’s disease, Parkinson’s disease, frontotemporal lobar degeneration, and multiple system atrophy are centrally characterized by the accumulation of pathological proteins in the brain. The intricate tapestry of neurodegenerative diseases reveals how specific proteins form complex aggregates that [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">279908</post-id>	</item>
	</channel>
</rss>
